60 Degrees Pharmaceuticals, Inc. (SXTP) financial statements and ratios from SEC XBRL: revenue $1.01M (TTM), net margin -732.5%, revenue growth 65.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.01M |
| Net Margin | -732.5% |
| Revenue Growth (YoY) | 65.5% |
| EPS Growth (YoY) | -36.8% |
| FCF Growth (YoY) | 21.5% |
| Price / Book | 1.17 |
| Price / Sales | 3.04 |
| FCF Yield | -534.0% |
| Altman Z-Score | -15.51 (distress) |
| Piotroski F-Score | 3/9 |
| Sector P/E (Healthcare) | 21.7 |
SXTP overview · SXTP earnings · SXTP KPIs · SXTP investor relations · SXTP ownership · SXTP peers · SXTP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.